Prognostic Impact Of Comorbidity In Multiple Myeloma

被引：1
|
作者：
Rios Tamayo, Rafael
Martinez Lopez, Joaquin
Jurado, Manuel
Clavero Sanchez, Maria Esther
Lopez Jimenez, Fatima
Paciello Coronel, Maria Liz
Garcia Fernandez, Jose Ramon
de la Torre, Youssef Moatassim
Lopez Berenguel, Francisco
Ferrer, Rosario Leyva
Sainz Perez, Juan
Molina Portillo, Elena
Sanchez Perez, Maria Jose
de Pablos Gallego, Jose Maria
Lopez Garrido, Pilar
Jimenez Moleon, Jose Juan
Lopez de Lacalle, Amaia
Lahuerta Palacios, Juan Jose
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.5340.5340
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5340
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Prognostic features of multiple myeloma
    San Miguel, JF
    García-Sanz, R
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2005, 18 (04) : 569 - 583
  • [42] A prognostic index for multiple myeloma
    Grignani, G
    Gobbi, PG
    Formisano, R
    Pieresca, C
    Ucci, G
    Brugnatelli, S
    Riccardi, A
    Ascari, E
    BRITISH JOURNAL OF CANCER, 1996, 73 (09) : 1101 - 1107
  • [43] INFECTIONS IN MULTIPLE MYELOMA: AN UNDERSTIMATE RISK FACTOR OF COMORBIDITY
    Barila, G.
    Compagno, N.
    Lico, A.
    Berno, T.
    Cinetto, F.
    Agostini, C.
    Semenzato, G.
    Zambello, R.
    HAEMATOLOGICA, 2016, 101 : 791 - 791
  • [44] Infections in Multiple Myeloma: An Understimate Risk Factor of Comorbidity
    Barila, Gregorio
    Compagno, Nicolo
    Lico, Albana
    Cinetto, Francesco
    Berno, Tamara
    De March, Elena
    Branca, Antonio
    Ammirati, Lucia
    Leoncin, Matteo
    Agostini, Carlo
    Semenzato, Gianpietro
    Zambello, Renato
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E30 - E30
  • [45] MULTIPLE MYELOMA AND COMORBIDITY: A POPULATION-BASED STUDY
    Sverrisdottir, I. S.
    Rognvaldsson, S.
    Lund, S. H.
    Turesson, I.
    Hultcrantz, M.
    Bjorkholm, M.
    Landgren, O.
    Kristinsson, S. Y.
    HAEMATOLOGICA, 2017, 102 : 270 - 270
  • [46] Multiple myeloma and comorbidity: a population-based study
    Sverrisdottir, Ingigerdur
    Rognvaldsson, Solvi
    Turesson, Ingemar
    Hultcrantz, Malin
    Bjorkholm, Magnus
    Landgren, C. Ola
    Kristinsson, Sigurdur
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E219 - E219
  • [47] Treatment Burden in Patients with Multiple Myeloma According to Comorbidity
    Perez Persona, Ernesto
    Unamunzaga Cilaurren, Ariane
    Vega Gonzalez de Vinaspre, Ana
    Oiartzabal Ormategui, Itziar
    Santamaria Lopez, Ana
    Cuevas Palomares, Laida
    Robles De Castro, Diego
    de Miguel Sanchez, Carlos
    Gabilondo Jalon, Miren
    Pereda Vicandi, Angel
    Mendizabal, Arantza
    Maria Guinea de Castro, Jose
    BLOOD, 2018, 132
  • [48] Comparison of the prognostic significance of 5 comorbidity scores and 12 functional tests in a prospective multiple myeloma patient cohort
    Scheubeck, Sophia
    Ihorst, Gabriele
    Schoeller, Katja
    Holler, Maximilian
    Moeller, Mandy-Deborah
    Reinhardt, Heike
    Waesch, Ralph
    Engelhardt, Monika
    CANCER, 2021, 127 (18) : 3422 - 3436
  • [49] The prognostic impact of inflammatory factors in patients with multiple myeloma treated with thalidomide in Korea
    Kim, Cheolsu
    Lee, Ho Sup
    Min, Chang-Ki
    Lee, Je Jung
    Kim, Kihyun
    Yoon, Dok Hyun
    Eom, Hyeon Seok
    Lee, Hyewon
    Lee, Won Sik
    Shin, Ho-Jin
    Lee, Ji Hyun
    Park, Yong
    Jo, Jae-Cheol
    Do, Young Rok
    Mun, Yeung-Chul
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2015, 30 (05): : 675 - 683
  • [50] Prognostic Impact of Cytogenetic Abnormalities in Multiple Myeloma: A Retrospective Analysis of 229 Patients
    Jian, Yuan
    Chen, Xiaolei
    Zhou, Huixing
    Zhu, Wanqiu
    Liu, Nian
    Geng, Chuanying
    Chen, Wenming
    MEDICINE, 2016, 95 (19)
12345